Greycoat shows flair in property

The Investment Column

It can be difficult peering through the boardroom shenanigans at Greycoat to see what is going on at the trading level. The departure of Brian Myerson from his non-executive directorship a couple of months ago was a typical distraction but it shouldn't draw too much attention away from what is one of the property sector's more interesting plays currently.

Not that that is much of a distinction in an industry that has studiously failed to live up to expectations of recovery over the past two or three years. Making money out of commercial bricks and mortar has become too tricky for many in the game and share prices, despite a recent flicker of interest, have been dull in the extreme.

If truth be told that is probably the real reason behind the recent bust- up between Mr Myerson, whose UK Active Value fund is Greycoat's second- largest shareholder, and the company's management. UKAV never made any money by sitting quietly on its hands and, having made less than it might have hoped out of Greycoat's restructuring, it probably thought it was time it stirred the pot a little.

The sale yesterday of one of Greycoat's largest investment properties, a big office building in Victoria, let to the government, is an interesting development. Releasing funds for smaller, more liquid investments, which offer scope to raise value by letting space and rejigging leases, is a sensible course of action in a market characterised by persistently flat capital and rental values.

The complaint of Mr Myerson that Greycoat's management would use the funds to kick start its nascent development programme, providing the capital to make the mistakes that brought it to the brink of collapse in 1993, seems wide of the mark. The funds are firmly earmarked for investment, the company says.

Not that it isn't dipping its toe in central London developments again, but the funds for that, pounds 12m from the sale of a 50 per cent interest in a City office development that has been shelved for this cycle, is relatively small beer compared to the net pounds 34m from the Buckingham Palace Road sale to CINMan.

Greycoat believes that the next year or so will provide a narrow window of opportunity to build profitably in the City and West End, where a shortage of well appointed buildings is pushing rents higher. It is probably right and as one of the most focused London developers, the company provides one of the best exposures for anyone with faith in the capital's property market.

In a rising market any fool can make money out of property, but when the sector is in the doldrums, property companies need a bit of imagination to make their assets sweat. Hammerson and Argent are doing it, and so, it would, appear is Greycoat. A strong hold.

S&N buys into biotech

Ever so quietly, Smith & Nephew is turning itself from a rather dull, broadly based health-care group into something a lot more focused and exciting. After last year's disposals of surgical gloves, washroom supplies and the last remaining pharmaceuticals business, the group is pared back to medical areaswhere it has strong positions.

But the latest deal with Advance Tissue Sciences of La Jolla in California, announced yesterday, proves that the group is also up with the best when it comes to signing up biotechnology groups at the leading edge of medical science. Capitalised at $500m on the US Nasdaq, ATS has discovered a way of artificially growing skin from human cells held in "tissue banks". The initial target of the new treatment, called Dermagraft, is for use in $2.5bn market for dealing with foot ulcers in diabetics.

An eight-week course of surgery using artificially cultured skin could prevent amputation of the limb and would represent an enormous saving on hospital and nursing costs. Smith & Nephew remains cagey but further development holds out promise for treating other wounds, such as those caused by burns, bed sores and leg ulcers.

The group is paying ATS $10m down for a 50 per cent share in a new joint venture to develop the treatment and is committed to two further $5m payments. Thereafter it pays $10m for every $100m of sales achieved by Dermagraft, up to a maximum of $50m. Given the experience of previous innovations, such as Opsite and Allevyn, Smith & Nephew's moist wound dressings, the group is estimating the $500m sales required to achieve the top payout could take 10 years to achieve.

But, assuming margins of well over 20 per cent, that could be chipping in profits of pounds 45m by then. In the meantime, a 1994 deal signed with ATS for the development of artificial cartilage could be bearing fruit.

Dermagraft should receive approval from the US Food & Drug Administration next year and be on the market in 1997. The shares, up 3p at 187.5p, stand on a forward multiple of 16, assuming profits of pounds 195m this year. Although mildly dilutive in the first full year, the ATS deals offer a low risk way of cashing in on the biotech boom. Hold.

Ashbourne

disappoints

Despite the quality of its nursing homes, Ashbourne has not proved a high-class investment for shareholders who bought in at the November 1994 placing. Since then, the shares have barely peeped above their 150p issue price and remain well short of it, despite yesterday's 2p rise to 139p.

Interim results showing a 57 per cent rise in pre-tax profits to pounds 4.9m in the 26 weeks to March were respectable enough. But in its short life on the stock market, Ashbourne has consistently disappointed expectations. The problem is its insistence on developing its own business from scratch when the outlook for the nursing home market is looking increasingly cloudy.

The acceleration in the group's opening programme to 400-500 new beds a year has had an inevitable effect on occupancy levels. Mature homes remain well insulated from the market's vagaries. Occupancy rates at 85 per cent are only down 3 percentage points since October and margins are still typically 35 per cent. But the dilution caused by 25 per cent of the portfolio being less than two years old means overall occupancy has plunged 10 points to 72 per cent in the past six months .

Ashbourne points to the pounds 1.94m exceptional gain in these figures on the sale and lease-back of five of its homes as an indicator of the hidden value within the group. The group argues it could cope with double the current pounds 32m of assets under lease and still take on pounds 60m of debt, racking up development profits as it sells off mature homes.

While this shows a commendable determination in resisting share issues, gearing of 200 per cent and upwards-only rent reviews would leave the company dangerously exposed. Profits of pounds 6.5m in the full year would put the shares on a forward p/e of 13, assuming 15 per cent tax. Only worth holding while 25 per cent holder Sun Healthcare decides whether to bid.

Start your day with The Independent, sign up for daily news emails
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Life and Style
techPatent specifies 'anthropomorphic device' to control media devices
Voices
The PM proposed 'commonsense restrictions' on migrant benefits
voicesAndrew Grice: Prime Minister can talk 'one nation Conservatism' but putting it into action will be tougher
News
Ireland will not find out whether gay couples have won the right to marry until Saturday afternoon
news
News
Kim Jong-un's brother Kim Jong-chol
news
News
Manchester city skyline as seen from Oldham above the streets of terraced houses in North West England on 7 April 2015.
news
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Software Developer / C# Developer

£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

Neil Pavier: Management Accountant

£45,000 - £55,000: Neil Pavier: Are you looking for your next opportunity for ...

Sheridan Maine: Commercial Accountant

£45,000 - £55,000: Sheridan Maine: Are you a newly qualified ACA/ACCA/ACMA qua...

Laura Norton: Project Accountant

£50,000 - £60,000: Laura Norton: Are you looking for an opportunity within a w...

Day In a Page

Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

Sun, sex and an anthropological study

One academic’s summer of hell in Magaluf
From Shakespeare to Rising Damp... to Vicious

Frances de la Tour's 50-year triumph

'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
'That Whitsun, I was late getting away...'

Ian McMillan on the Whitsun Weddings

This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
Kathryn Williams explores the works and influences of Sylvia Plath in a new light

Songs from the bell jar

Kathryn Williams explores the works and influences of Sylvia Plath
How one man's day in high heels showed him that Cannes must change its 'no flats' policy

One man's day in high heels

...showed him that Cannes must change its 'flats' policy
Is a quiet crusade to reform executive pay bearing fruit?

Is a quiet crusade to reform executive pay bearing fruit?

Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
The King David Hotel gives precious work to Palestinians - unless peace talks are on

King David Hotel: Palestinians not included

The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
More people moving from Australia to New Zealand than in the other direction for first time in 24 years

End of the Aussie brain drain

More people moving from Australia to New Zealand than in the other direction for first time in 24 years
Meditation is touted as a cure for mental instability but can it actually be bad for you?

Can meditation be bad for you?

Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

Australia's first-ever Eurovision entrant

Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine
Letterman's final Late Show: Laughter, but no tears, as David takes his bow after 33 years

Laughter, but no tears, as Letterman takes his bow after 33 years

Veteran talkshow host steps down to plaudits from four presidents
Ivor Novello Awards 2015: Hozier wins with anti-Catholic song 'Take Me To Church' as John Whittingdale leads praise for Black Sabbath

Hozier's 'blasphemous' song takes Novello award

Singer joins Ed Sheeran and Clean Bandit in celebration of the best in British and Irish music
Tequila gold rush: The spirit has gone from a cheap shot to a multi-billion pound product

Join the tequila gold rush

The spirit has gone from a cheap shot to a multi-billion pound product
12 best statement wallpapers

12 best statement wallpapers

Make an impact and transform a room with a conversation-starting pattern
Paul Scholes column: Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?

Paul Scholes column

Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?